NCT06324448View on ClinicalTrials.gov

Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions
Parkinson Disease
Interventions
DEVICE

Transcranial direct current stimulation

tDCS self-administered at home once a day for 28 consecutive days for a total of 28 sessions (one session consists of 20 minutes through two saline-soaked sponge electrodes (diameter 6cm) using the YMS-201B (Ybrain Inc, South Korea)).

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER